Edition:
United Kingdom

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

37.44USD
19 Apr 2018
Change (% chg)

$-1.09 (-2.83%)
Prev Close
$38.53
Open
$38.33
Day's High
$38.71
Day's Low
$37.32
Volume
67,669
Avg. Vol
112,137
52-wk High
$46.81
52-wk Low
$29.58

Chart for

About

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $1,667.74
Shares Outstanding(Mil.): 43.51
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 75.20 30.95 32.74
EPS (TTM): 0.51 -- --
ROI: 6.40 14.84 14.38
ROE: 9.98 16.34 16.07

BRIEF-Repligen Reports Q4 GAAP Earnings Per Share $0.27

* REPLIGEN REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS, PROVIDES GUIDANCE FOR 2018

22 Feb 2018

BRIEF-Repligen reports Q3 adjusted non-GAAP earnings per share $0.15

* Q3 earnings per share view $0.11 -- Thomson Reuters I/B/E/S

09 Nov 2017

BRIEF-Repligen extends long term supply agreement with Purolite for Protein A ligands

* Repligen extends long term supply agreement with Purolite for Protein A ligands

07 Nov 2017

Competitors

Earnings vs. Estimates